Form 8-K - Current report:
SEC Accession No. 0001213900-21-050592
Filing Date
2021-09-29
Accepted
2021-09-29 16:37:11
Documents
30
Period of Report
2021-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147929-8k_jasper.htm   iXBRL 8-K 275631
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF JASPER THERAPEUTICS, INC ea147929ex3-1_jasper.htm EX-3.1 46690
3 AMENDED AND RESTATED BYLAWS OF JASPER THERAPEUTICS, INC ea147929ex3-2_jasper.htm EX-3.2 149404
4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2021, BY ea147929ex10-2_jasper.htm EX-10.2 184599
5 JASPER THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN ea147929ex10-3_jasper.htm EX-10.3 229845
6 JASPER THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN FORM OF STOCK OPTION GRANT ea147929ex10-4_jasper.htm EX-10.4 41840
7 JASPER THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN FORM OF RSU AWARD GRANT NOT ea147929ex10-5_jasper.htm EX-10.5 31496
8 JASPER THERAPEUTICS, INC., 2021 EMPLOYEE STOCK PURCHASE PLAN ea147929ex10-6_jasper.htm EX-10.6 105346
9 EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND BETWEEN JASPER THER ea147929ex10-7_jasper.htm EX-10.7 53031
10 EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND BETWEEN JASPER THER ea147929ex10-8_jasper.htm EX-10.8 54425
11 EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND BETWEEN JASPER THER ea147929ex10-9_jasper.htm EX-10.9 63326
12 AMENDMENT TO SPONSOR SUPPORT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND A ea147929ex10-14_jasper.htm EX-10.14 16898
13 CODE OF BUSINESS CONDUCT AND ETHICS ea147929ex14-1_jasper.htm EX-14.1 115673
14 LETTERTO SEC FROM WITHUMSMITH+BROWN, PC ea147929ex16-1_jasper.htm EX-16.1 2520
15 LIST OF SUBSIDIARIES ea147929ex21-1_jasper.htm EX-21.1 1203
16 PRESS RELEASE, DATED SEPTEMBER 24, 2021 ea147929ex99-1_jasper.htm EX-99.1 19707
17 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF THE COMPANY AS O ea147929ex99-2_jasper.htm EX-99.2 200185
22 GRAPHIC ex99-1_001.jpg GRAPHIC 3851
  Complete submission text file 0001213900-21-050592.txt   2149641

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE amhc-20210924.xsd EX-101.SCH 3934
19 XBRL DEFINITION FILE amhc-20210924_def.xml EX-101.DEF 28929
20 XBRL LABEL FILE amhc-20210924_lab.xml EX-101.LAB 38896
21 XBRL PRESENTATION FILE amhc-20210924_pre.xml EX-101.PRE 27132
23 EXTRACTED XBRL INSTANCE DOCUMENT ea147929-8k_jasper_htm.xml XML 7312
Mailing Address 1177 AVENUE OF THE AMERICAS FL 40 NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS FL 40 NEW YORK NY 10036 212- 823-1900
Amplitude Healthcare Acquisition Corp (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39138 | Film No.: 211292166
SIC: 2836 Biological Products, (No Diagnostic Substances)